第一单位：
Paris University, AP-HP, Hôpital Saint-Louis, Unité de Thérapie Cellulaire et Centre MEARY de Thérapie Cellulaire et Génique, Paris, France; Stem Cell Biotechnologies, U976 et Centre d'Investigation Clinique en Biothérapies CIC-BT CBT501, INSERM, Paris, France; Sorbonne University, AP-HP, Trousseau Hospital, DMU ORIGYNE, Department of Fetal Medicine, Paris, France; National Reference Center for Rare Disease: Vertebral and Spinal Cord Anomalies (MAVEM Center), AP-HP, Trousseau Hospital, Paris, France. Electronic address: lucie.guilbaud@aphp.fr.
作者：
Lucie,Guilbaud [1]
;
Anaïs,Dugas [2]
;
Mathilde,Weber [3]
;
Carole,Deflers [3]
;
Pauline,Lallemant [4]
;
Thomas,Lilin [5]
;
Clovis,Adam [6]
;
Audrey,Cras [7]
;
Miryam,Mebarki [3]
;
Michel,Zérah [8]
;
Lionel,Faivre [3]
;
Jérôme,Larghero [3]
;
Jean-Marie,Jouannic [9]
作者单位：
Paris University, AP-HP, Hôpital Saint-Louis, Unité de Thérapie Cellulaire et Centre MEARY de Thérapie Cellulaire et Génique, Paris, France; Stem Cell Biotechnologies, U976 et Centre d'Investigation Clinique en Biothérapies CIC-BT CBT501, INSERM, Paris, France; Sorbonne University, AP-HP, Trousseau Hospital, DMU ORIGYNE, Department of Fetal Medicine, Paris, France; National Reference Center for Rare Disease: Vertebral and Spinal Cord Anomalies (MAVEM Center), AP-HP, Trousseau Hospital, Paris, France. Electronic address: lucie.guilbaud@aphp.fr.
[1]
Paris University, AP-HP, Hôpital Saint-Louis, Unité de Thérapie Cellulaire et Centre MEARY de Thérapie Cellulaire et Génique, Paris, France; Stem Cell Biotechnologies, U976 et Centre d'Investigation Clinique en Biothérapies CIC-BT CBT501, INSERM, Paris, France; Sorbonne University, AP-HP, Trousseau Hospital, DMU ORIGYNE, Department of Fetal Medicine, Paris, France; National Reference Center for Rare Disease: Vertebral and Spinal Cord Anomalies (MAVEM Center), AP-HP, Trousseau Hospital, Paris, France.
[2]
Paris University, AP-HP, Hôpital Saint-Louis, Unité de Thérapie Cellulaire et Centre MEARY de Thérapie Cellulaire et Génique, Paris, France; Stem Cell Biotechnologies, U976 et Centre d'Investigation Clinique en Biothérapies CIC-BT CBT501, INSERM, Paris, France.
[3]
National Reference Center for Rare Disease: Vertebral and Spinal Cord Anomalies (MAVEM Center), AP-HP, Trousseau Hospital, Paris, France; Sorbonne University, AP-HP, Trousseau Hospital, Department of Physical Medicine and Rehabilitation, Paris, France.
[4]
Center for Biomedical Research, National Veterinary School, Maisons Alfort, France.
[5]
Paris Saclay University, Kremlin Bicêtre Hospital, Department of Pathology, Le Kremlin-Bicêtre, France.
[6]
Paris University, AP-HP, Hôpital Saint-Louis, Unité de Thérapie Cellulaire et Centre MEARY de Thérapie Cellulaire et Génique, Paris, France; Paris university, Innovative Therapies in Haemostasis, UMR1140 and Centre d'Investigation Clinique en Biothérapies CIC-BT CBT501, INSERM, Paris, France.
[7]
National Reference Center for Rare Disease: Vertebral and Spinal Cord Anomalies (MAVEM Center), AP-HP, Trousseau Hospital, Paris, France; Paris University, AP-HP, Necker Enfants Malades Hospital, Department of Pediatric Neurosurgery, 149 Rue de Sèvres, 75015 Paris, France.
[8]
Sorbonne University, AP-HP, Trousseau Hospital, DMU ORIGYNE, Department of Fetal Medicine, Paris, France; National Reference Center for Rare Disease: Vertebral and Spinal Cord Anomalies (MAVEM Center), AP-HP, Trousseau Hospital, Paris, France.
[9]
DOI
10.1016/j.retram.2021.103314
PMID
34731725
发布时间
2022-01-26
换一批
